Higher Tinzaparin Dosing Is Needed to Achieve Target Anti-Xa Levels in Pediatric Cardiac Intensive Care Patients

Roeleveld, P.P.; Hoeven, A. van der; Wilde, R.B.P. de; Eikenboom, J.; Smiers, F.J.; Bunker-Wiersma, H.E. (2016)

Article / Letter to editor

• anti-Xa
• child
• pediatric intensive care
• pharmacokinetics
• low-molecular weight heparin
• tinzaparin

• All authors: Roeleveld, P.P.; Hoeven, A. van der; Wilde, R.B.P. de; Eikenboom, J.; Smiers, F.J.; Bunker-Wiersma, H.E.
• Date: 2016-03-31
• Journal: Pediatric Critical Care Medicine
• Volume: 17
• Issue: 3
• Pages: 203 - 209
• DOI: doi:10.1097/PCC.0000000000000640